Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NeoCannBio logo — Harnessing nature's bounty to craft innovative therapies and...

NeoCannBio

Harnessing nature's bounty to craft innovative therapies and building a comprehensive cannabinoid library from hemp and medical cannabis.

Founded 2021 Series B Total: $14.50B Biopharma, Health Care

General Information

Company Name NeoCannBio
Founded Year 2021
Industries Biopharma, Health Care
Funding Stage Series B
Social

Get notified when NeoCannBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeoCannBio

NeoCannBio is a biopharmaceutical startup that is harnessing nature's bounty to craft innovative therapies and build a comprehensive cannabinoid library from hemp and medical cannabis. Established in 2021, the company focuses on natural product processing facilities to generate new medications derived from natural goods. Its efforts have resulted in the development of a cannabinoid library comprising hemp and medical cannabis extracts. The company operates within the Biopharma and Health Care industries, indicating its commitment to advancing medical treatments and healthcare solutions. In its most recent funding round, NeoCannBio secured a noteworthy KRW10.00B Series B investment on 26 September 2023. The investment came from a consortium of prominent investors, including QUAD Investment Management, Medytox Venture Investment, Prologue Ventures, Bilanx Investment, Donghoon Investment, BM Ventures, and HLB Group. This substantial investment signifies growing confidence in the company's mission and potential to make a significant impact in the biopharmaceutical and healthcare sectors. Overall, NeoCannBio is strategically positioned to leverage its innovative approach to natural product processing and its expanding cannabinoid library to develop groundbreaking medications and advance the field of medical cannabis and hemp-derived therapies. The substantial Series B investment and the support from an array of reputable investors further validate the company's prospects and may herald a promising future in the healthcare and biopharmaceutical arenas.

Taxonomy: natural products, therapies, cannabinoids, medications, hemp processing, medical cannabis, innovation, biopharmaceuticals, drug development, natural remedies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 7
Investor Investor Investor Investor Investor
•••• •••• 		26 Sep 2023
Series A •••••• 3
Investor
•••• •••• 		01 Jul 2022

NeoCannBio Alternatives & Competitors

NeoCannBio vs
Cambium Analytica
Cambium Analytica United States

Cambium is a full service provider of analytical testing, product research & development, and QA/QC...

74 employees
Biotechnology
Compare NeoCannBio vs Cambium Analytica
NeoCannBio vs
Madina Industrial Corp
Madina Industrial Corp United States

Manufacturers of natural, alcohol-free fragrances and skin care products. Serving customers worldwid...

9 employees
Manufacturing, Retail
NeoCannBio vs
Lewis Family Natural Health
Lewis Family Natural Health

Providing health through nutritional supplements, homeopathic remedies, and natural skincare, all cr...

2-10 employees
Health Care, Pharmaceutical

FAQ About NeoCannBio

Harnessing nature's bounty to craft innovative therapies and building a comprehensive cannabinoid library from hemp and medical cannabis.
NeoCannBio was founded in 2021.
NeoCannBio operates in the following industries: Biopharma, Health Care.
NeoCannBio has completed 2 funding rounds, raising a total of $14.50B. The latest funding stage is Series B.
Top alternatives and competitors to NeoCannBio include Cambium Analytica, Madina Industrial Corp, Lewis Family Natural Health, Conversate, NMPP Energy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeoCannBio and Cambium Analytica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NeoCannBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes